Zuvest
← All research
Latest research ·

AAPL Apple Inc.

Technology · Consumer Electronics
$353.24
+0.38% on the day · price at time of report
Neutral
CautiousNeutralConstructive

Verdict by horizon

Long-term investing
Wait for a better price

The market thinks Apple deserves a premium for durable ecosystem cash flows and re-accelerating growth; I agree the quality is exceptional, but at 33x forward earnings and a 2.65% FCF yield versus a 5.06% risk-free rate, the price already discounts the good sc

Swing trading
No valid setup

A pullback toward 347.7 (21 EMA) to 349.27 (S1), with lighter volume and a reversal candle. For the breakout, wait for a close above 360.83 on at least 1.5x average volume and SPY stabilizing above its 50-day.

Day trading
Bias: neutral

RVOL 4.67 at 12:24 ET, so the stock is active. Price 353.24 is above VWAP 352.92 after 9 VWAP crosses, which points to a range day. The gap is flat (-0.01%) and there is no catalyst, with earnings 71 days away. Range used is 61% of the 8.1 ADR. HOD is 356.42 a

Options
No structure

FAIR - 30d ATM IV 24.8% vs HV20 27.2% (IV/HV20 0.91) and HV60 22.1%; term structure normal/flat; 25d put-minus-call skew 5.3 pts (30d), which shows some demand for protection; IV rank unknown (no IV history). Next earnings 2027-01-28 is outside every listed ex

Views by discipline

▤ Fundamentals & valuationneutral · 62
⌕ Accounting quality & eventsneutral · 70
◍ Macro, policy & creditneutral · 55
⟋ Technical analysisbullish · 62
⇄ Positioning & sentimentneutral · 55

Valuation snapshot

Fair value (bear / base / bull)$150.00 / $235.00 / $320.00
Street mean target$345.63
P/E fwd · FCF yield · ROIC33.4 · 2.65% · 96.8%

Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories, including Apple Watch, AirPods, Beats products, Apple Vision Pro, Apple TV 4K, HomePod, and Apple HomeView, as well as Apple branded and third-party accessories. It also provides advertising services comprising third-party

Charts

Price, indicators & swing plan

Intraday & day-trade plan

Research views

Valuation

Relative strength

Fundamentals

Options

Market backdrop

Research memo

Bottom line

  • Long-term investing: wait. Do not buy at today's price. Apple looks like an "A" grade business (ROIC 96.8% vs WACC 10.28%; forensic verdict CLEAN). The price is the problem. The stock is at $353.24, above even the fundamental analyst's bull value of $320. The forward P/E is 33.4x, and the FCF yield of 2.65% is well below the 5.06% 10-year Treasury yield. Existing holders can reasonably keep their shares. New money has no margin of safety.
  • Swing trading: no approved trade today. The chart is a strong Stage 2 leader (Trend Template 8/8, RS line at a 52-week high). the risk review rejected the submitted pullback plan because its reward-to-risk was 1.0 against a 2.0 minimum. The idea is to be re-planned, not acted on.
  • Day trading: one small, conditional setup only. The VWAP-pullback long was approved at reduced size, in the 14:00–15:00 ET window, and only with confirmation. The HOD-break long and the VWAP-rejection short were both rejected.
  • Options: none. Every candidate structure's maximum loss exceeds the $100 options-risk cap (1% of the account).
  • Most important risk: the market regime. SPY sits only 0.01% above its 200-day, with 8 distribution days in 25 sessions and VIX at 25.48 in backwardation. A sharp sell-off could hit a crowded defensive winner like AAPL hard, even though its own trend is strong.

Long-term investment view

Stance: neutral / wait for a better price. Medium confidence.

For a multi-year horizon, the strongest evidence is fundamental, forensic and macro. These three lenses agree: Apple is a great business at a full price.

The business is excellent: - ROIC 96.8% vs WACC 10.28%, so each dollar Apple reinvests creates a lot of value. - Margins are expanding. Gross margin rose from 44.1% to 48.8% and operating margin from 29.8% to 33.0%. - Revenue growth re-accelerated to 15.06% in FY2026, up from 6.43% and 2.02% in the prior two years. The 4-year compound growth rate is still only 7.7%. - Cash generation is high. FCF conversion was 103%, and diluted shares fell from 15,812m to 14,720m through buybacks. - The forensic scores are clean. Beneish M-Score is −2.49 (no sign of earnings manipulation), Piotroski F-Score is 9/9 (maximum financial strength), and Altman Z is 13.05 (very low distress risk).

The price already assumes a lot. - Reverse DCF: a reverse DCF works backward from today's price to the growth the market must be assuming. Here it implies about 29.8% starting growth, versus 7.7% historically. That is a very demanding bar. - Valuation ratios: PEG is 2.84 (above 2 is usually considered expensive). EV/EBITDA is 30x. - Sell-side targets: the mean analyst target is $345.63, about 2% below the price. - Variant perception: this is a view that differs from consensus, with evidence for why the market is wrong. Nobody upstream has one on the upside. Without one says to assume the good news is already priced in.

Fair value: the fundamental analyst's judgment-based range is bear $150 / base $235 / bull $320. - These are not mechanical outputs. The raw DCF gave about $148, which the analyst judged too harsh. - As an illustration only, an equal-tails 25/50/25 weighting (as) gives about $235. That is far below $353. - Treat this as a sign of how much optimism the price contains, not a precise target.

The plan: - The fundamental analyst's accumulation zone is $230–265. - It separately says a pullback to $250–290 with intact fundamentals would change its mind. Read the overlap, roughly the $250–265 area, as where its two statements agree.

Macro context: - A 5.06% 10-year yield and 4.08% CPI are headwinds for richly valued stocks. - AAPL has behaved defensively, with beta of 0.61 by one measure. A second source shows 1.09, so true market sensitivity is uncertain.

What would prove the "wait" view wrong: - Sustained double-digit revenue growth with continued margin expansion. - The 10-year yield falling meaningfully below ~4.5–5%, which would lower the discount rate.

What would break the long-term thesis for holders: - Revenue growth falling below ~5% while the P/E stays above 30x. - Operating margin falling below ~30%. - FCF conversion persistently well below 90%.

Swing trading view

Stance: constructive chart, but no approved trade.

For a swing horizon (days to weeks), the most relevant evidence is technicals, flow and the market regime. Here they pull in different directions.

For the long side: - Stage 2 uptrend, meaning price is above a rising 30-week moving average. - Price 353.24 is above the SMA50 (340.93), SMA150 (316.11) and SMA200 (302.08). - The RS line is at a 52-week high, and AAPL is +17.59 points vs SPY over 3 months.

Against it: - ADX is 18.1, which signals a weak trend or a range. - Volume does not confirm. CMF20 is −0.025, OBV is falling, and there have been 4 distribution days in AAPL itself. - The base is not a clean volatility contraction pattern (VCP): pullback depths went 11.83% → 6.86% → 11.0%. - The overall market is under institutional selling.

Why the risk review rejected the plan. The plan was a limit buy at 348.5 with a stop at 338.0, a risk of 10.5 points. - Its first target of 359.0 is only 10.5 points away. That is 1.0R, not the 2R the plan claimed, below the 2.0 swing minimum. - A true 2R target would need about 369.5. That sits above the 360.83 pivot, so the trade would have to break through resistance just to reach its first target. - The plan is internally inconsistent, so it is off the table as written.

What a valid future plan needs: - Either a tighter, still-logical stop, or a breakout entry above 360.83 confirmed by volume of at least 1.5x average. - In either case, the plan must clear the 2:1 rule before entry, and must be re-submitted to the risk review. - Given the Yellow-to-Red regime, any re-submitted plan should also expect reduced size.

Day trading view (today / next session)

Stance: neutral. At most one small, conditional long.

The tape looks like a range day: - 9 crosses of VWAP, the volume-weighted average price where the average share traded today. - A flat gap and no catalyst. - Midday chop.

The stock is "in play" (RVOL 4.67 earlier in the session), but activity is not the same as an edge.

Approved, at reduced size: VWAP pullback long - Trigger: a pullback to VWAP (~352.9) on lighter volume, then a green reversal candle that holds above VWAP and the prior-day close (351.91). - Entry / stop: entry ~353.3, hard stop 351.3, entered as a bracket order at entry and never widened. - Targets: 356.4, then 358.0. Reward-to-risk is only 1.55, barely above the 1.5 day-trade minimum, so the edge is thin. - Window: the morning window has passed, so only 14:00–15:00 ET remains. - Skip conditions: - SPY is making new lows. - A 5-minute close below the low of day (351.47). - The trade would be your 4th day trade in 5 business days in a US margin account under $25k (pattern-day-trader rule).

Rejected: - HOD-break long: 1.0R to the first target. The 360 round number and the 360.83 pivot are too close overhead. - VWAP-rejection short: 0.81R. It is also counter-trend against a Stage 2 leader.

Account guardrails: - 1R = $50 and the daily loss cap is $200. - Three-strikes rule: stop after 3 losing trades in a day. - No new day trades after 15:30 ET.

Behavioral trap to name: the stock is about 2% under its high and active, which invites chasing. The rule is: no setup, no trade.

Options view

No structure is recommended. The options analyst and the risk review agree.

  • Volatility is fairly priced. 30-day ATM implied volatility is 24.8% vs 20-day historical volatility of 27.2% (ratio 0.91). Earnings fall outside the listed expiries, so there is no IV-crush effect to exploit.
  • Every candidate breaches the $100 options-risk cap. The cheapest bullish idea, the Dec-18 355/360 bull call debit spread, has a $260 maximum loss. Contracts cannot be split, so it cannot be sized down to fit (: size by maximum loss).
  • The other ideas are also out:
  • Cash-secured puts would need far more cash than the account holds.
  • Covered calls require owning 100 shares, which would exceed the 25% position cap.
  • The 5-day weekly options are illiquid, with a 7% bid-ask spread and high gamma.

What the options market says is still useful information: - The Dec-18 expected move is ±5.7%, a range of about 333.09–373.39. - A 25-delta put-minus-call skew of 5.3–7.0 points shows some demand for downside protection.

Where the analysts disagree

  1. Technical (bullish) vs fundamental (neutral, expensive). Both can be right on different horizons.
  2. The trend is a weeks-to-months fact.
  3. Valuation matters more over years.
  4. For investing, fundamentals carry more weight. For swing trades, the chart and the regime do.
  5. Defensive leader vs crowding risk. Macro sees AAPL's leadership (+24.58 points vs its sector over 3 months) as a strength in a risk-off market. The same analyst and the flow analyst warn that crowded winners can reverse sharply if selling becomes indiscriminate.
  6. Beta discrepancy (0.61 vs 1.09). Two sources disagree on market sensitivity. the risk review correctly sizes as if the higher figure is true.
  7. The swing plan contradicted itself. It claimed 2R at 359.0, but the arithmetic gives 1.0R. the risk review caught this. That is a good lesson in recomputing derived numbers yourself.
  8. Earnings track record vs reactions. All 8 past EPS reports beat estimates, yet the stock fell after 6 of them. "Beat" does not equal "rally" when expectations are high.
  9. Fundamental buy zone wording. The analyst gives $230–265 in its plan but $250–290 in its "change my mind" list. The overlap is the more defensible reading.
  10. Minor data inconsistencies:
  11. The technical analyst lists the earnings date as unknown, but FACTS show 2027-01-28.
  12. The forensic inventory flag (+154.3% vs revenue +15.06%) conflicts with the other indices and is likely a data artifact. It still needs verification.

What to watch next (catalysts, levels, data)

Market regime - SPY close vs its 200-day. A close below it flips the regime to downtrend: cut exposure and tighten stops. - VIX vs VIX3M. A return to contango (VIX below VIX3M) and VIX under 20 would be a tailwind. - 10-year yield above ~5.25%. - High-yield spread above ~4.5pp (now 3.43pp).

AAPL price levels - Upside: a close above 360.83 on at least 1.5x average volume is the breakout trigger for re-planning a swing. A close back below it within 1–3 days marks a failed breakout. - Downside: - 347.7 (21 EMA) and 349.27 (S1) form the pullback zone. - A daily close below 340.93 (SMA50) or 338.44 turns the chart neutral or bearish. - Relative strength: the RS line rolling over from its 52-week high would be an early warning.

Data to verify - Direction and 10b5-1 status of the recent Form 4 and 144 filings (there were 19 insider sales worth $111.86M in 180 days, with no buys). - The security type of the 424B2 filings (likely debt). - The inventory footnote in the 10-K. - The next 13F for changes by the top holders.

Catalyst - Earnings on 2027-01-28, with EPS estimated at $2.91 and revenue at $156.43B. - The average post-earnings move is 2.53%; the worst was −7.35%.

Risk-checked trade plans

Trade plans are illustrative and were risk-checked against a reference $10,000 model portfolio (0.5% risk per trade); any share counts refer to that model portfolio.

dayHOD break (afternoon continuation)longrejected
Entry356.50
Stop353.90
Targets359.10, 360.00
Reward : risk1.00

Risk review: Hard violation: reward:risk to the first target is 1.00, below the 1.5 minimum for day trades. The planned entry at 356.5 has only about 1.4R-1.5R of room before the 360 round number and the 360.83 pivot. It would also use up a scarce PDT day trade. Position size is capped at 25% (7 shares).

dayVWAP pullback / mean reversion long in a rangelongreduced size
Entry353.30
Stop351.30
Targets356.40, 358.00
Reward : risk1.55

Risk review: Valid: reward:risk is 1.55, just above the 1.5 minimum. Python sizing is 7 shares with $14 of risk (0.14% of the account), well under the $50 1R budget. The edge is thin. VIX is 25.48 in backwardation, the stock has had 9 VWAP crosses (a chop day), and the 10:30-11:30 window may already be gone (now 12:24 ET). That leaves only the 14:00-15:00 window. Take it only with a confirmed green reversal candle holding VWAP and PDC, and only if SPY is not making new lows. Use a hard bracket order with the stop entered at 351.3 and never widen it. Use half of the 7 shares (3 shares), because the macro guidance is reduced size and the first target gives only 1.55R. Count it as one of the PDT day trades; if it would be the 4th in 5 days on a margin account under $25k, skip it.

dayVWAP rejection / failed breakout shortshortrejected
Entry352.80
Stop354.40
Targets351.50, 349.70
Reward : risk0.81

Risk review: Hard violation: reward:risk is 0.81, below the 1.5 minimum. This is also a counter-trend short against a Stage 2 leader with its RS line at a 52-week high. Squeeze risk is low (1.0% of float), but the structure still does not pay.

swingPullback to the 21 EMA / prior-day pivot zone within a Stage 2 uptrend (lower-risk alternative to the 360.83 breakout). The breakout above 360.83 is a secondary option that needs 1.5x volume.longrejected
Entry348.50
Stop338.00
Targets359.00, 369.50
Reward : risk1.00

Risk review: Hard violation: reward:risk to the first target is 1.00, below the 2.0 minimum for swings. The plan text claims 2R at 359.0, but from 348.5 with a 338.0 stop the first target gives only 1.0R, so the plan is internally inconsistent. Re-submit with a corrected target or a tighter stop. At that point, the setup (a pullback to the 21 EMA at about 347.7-349.3 in a regime that is Yellow-to-Red) would still need reduced size (4 shares at most, 0.42% risk). The idea is not dead, but this plan as written is.

Analysis by discipline

▤Fundamentals & valuation neutral · 62

Apple is an exceptional business with a very high ROIC (96.8%), 33% operating margins, FCF conversion of 103%, and shrinking share count. At $352.80 it trades at 39x trailing and 33x forward earnings with a 2.65% FCF yield, and the market already prices in rich expectations. The mechanical DCF ($148-150) looks too punitive, but even after adjusting it, the price leaves little margin of safety. Hold existing positions and wait for a better entry.

Key findings

  • Elite returns on capital point to a wide moat (brand, switching costs, ecosystem) ROIC 96.8% vs WACC 10.28%; ROE 117.9% (inflated by buybacks)
  • Growth re-accelerated in the latest year, but the 4-year CAGR is moderate Revenue growth 15.06% in FY2026 vs 6.43% and 2.02% prior; CAGR 7.7%; latest quarter yoy +11.72%
  • Margins are expanding steadily Gross margin 44.1% -> 48.8%; operating margin 29.8% -> 33.0%; net margin 27.6%
  • Cash generation is excellent and the share count keeps shrinking, though FCF is lumpy FCF $136.1B (103% conversion); FY2025 FCF fell to $98.8B (88%); diluted shares 15,812m -> 14,720m; SBC 2.9% of revenue
  • Balance sheet is not a concern Net debt $23.4B, net debt/EBITDA 0.14x; current ratio 1.02 (thin liquidity ratio but cash-rich)
  • Valuation is demanding relative to growth P/E 39.3x, forward 33.4x, PEG 2.84 (>2 is expensive), EV/EBITDA 30x, FCF yield 2.65% vs 10Y yield 5.06%

Risks

  • Multiple compression: a 5.06% risk-free rate makes a 2.65% FCF yield unattractive, and any growth disappointment could drop the P/E toward 25-28x
  • The growth acceleration may be a one-off product cycle rather than durable growth
  • Regulatory pressure on App Store and services, plus China and tariff or supply chain exposure (general risk; no facts supplied)
  • Stock is near its 52-week high ($360.83) after +32.5% in 1y, so sentiment is stretched
  • Latest FY FCF jumped 38%; reversion would weaken the valuation case
⌕Accounting quality & events neutral · 70

Apple's forensic scores are clean: Beneish M-Score is -2.49 (below -1.78), Piotroski F is 9/9, Altman Z is 13.05 (safe), and the accruals ratio is 3.0%. The one flag is a data item showing inventory up 154.3% against revenue up 15.06%, which looks like a likely data artifact and needs checking. The SEC feed shows routine activity (Form 4s, Form 144s, 424B2 debt-style prospectus supplements, no 4.01/4.02 items). The next key event is earnings on 2027-01-28. This is a screen, not a verdict, and it is education, not advice.

Key findings

  • Beneish M-Score shows no manipulation signal M = -2.49, below both -1.78 and -2.22. DSRI 0.957 and TATA -0.032 mean receivables are not outgrowing sales and profit is cash-backed. SGI 1.151 is the highest index but is not alarming.
  • Earnings are backed by cash Accruals ratio (CF) 3.0%, within the normal 0-10% band. FCF conversion is 103% in FY2026 (88% in FY2025, 116% in FY2024, 103% in FY2023). FCF is $136,056M vs net margin 27.6%.
  • Distress risk is negligible; Altman Z' is the better tool here Z = 13.05 (safe, >2.99), Z'' = 3.2 (safe, >2.60). Net debt/EBITDA 0.14x, net debt $23,389M. The current ratio of 1.02 is thin but offset by cash of $56,722M and strong cash generation. Scores are not designed for banks or insurers, but Apple is not one.
  • Financial strength is at the maximum Piotroski F = 9/9: ROA up, CFO positive, leverage down, current ratio up, no new shares (diluted shares 14,720M vs 15,005M), gross margin 48.8% vs 46.9%, turnover up.
  • Inventory flag needs verification but is probably not alarming Flag: inventory +154.3% vs revenue +15.06%. Contradicts the DSRI 0.957 and GMI 0.961 readings, margins are rising (48.8% vs 46.9%), and Apple's inventory is small. It could be a data or tagging error. The absolute inventory values are unknown. If real, it implies write-down risk.
  • Share-count and SBC are benign SBC is 2.9% of revenue (3.1% prior). Diluted shares fell from 15,812M to 14,720M over 3 years, so dilution is offset by buybacks.

Risks

  • The inventory flag could signal a real demand or write-down issue if the data is correct.
  • Insider Form 144 and Form 4 activity (26 and 6 in 90 days) could be cluster selling; direction is unverified.
  • Earnings gap risk: past worst move -7.35%, with negative reactions in 6 of the last 8 reports even on beats.
  • Thin current ratio 1.02.
  • Wide analyst target dispersion ($261-$425) suggests disagreement on valuation.
◍Macro, policy & credit neutral · 55

The macro backdrop is stressed: SPY is 4.22% below its 50-day (but flat on the 200-day), VIX is 25.48 in backwardation, and junk is underperforming. Rates are high (10y ~5.06%) and CPI is 4.08% yoy, a headwind for valuations. AAPL is acting as a defensive outlier, with a 3m relative strength of +17.59 pts vs SPY and a sensitivity beta of 0.61, so the macro verdict is NEUTRAL with reduced size.

Key findings

  • Market regime is an uptrend under pressure with institutional selling SPY vs SMA50 -4.22%, vs SMA200 +0.01%; 8 distribution days in 25 sessions; 1m change -5.07%
  • Volatility is in stress mode VIX 25.48 (+47.2% 1m), VIX > VIX3M (25.0) = backwardation; implied SPX daily move 1.61%
  • Credit is risk-off but not yet crisis-like HYG/LQD ratio 1m change -0.02% ('junk underperforming'); HY spread 3.43pp (+0.14 in 1m); HYG 1.08% below SMA200
  • Rates and inflation are a valuation headwind 10y 5.06% (FRED 5.12%), 2y 4.83%, CPI 4.08% yoy, Fed funds 3.88%; 10y-3m +0.77 to +0.92pp (not inverted)
  • Cycle looks late-cycle: inflation elevated, unemployment low, yet the Fed has trimmed rates Unemployment 4.1% (-0.3 over 12m); Fed funds -0.21 over 12m; CPI 4.08%; oil -20% 1m, copper -14% 1m (growth worries)
  • Sector (tech) is lagging SPY, but AAPL is leading both XLK 3m -11.02%, -6.99 pts vs SPY, -12.33% vs SMA50; AAPL +17.59 pts vs SPY and +24.58 pts vs XLK over 3m; RS line at 52-week high

Risks

  • Further equity de-risking: 8 distribution days and VIX backwardation could lead to a break below the SPY 200-day
  • Crowding into AAPL as a defensive winner (RS at a 52-week high) could reverse sharply if the selling becomes indiscriminate
  • A 10y yield above 5% with CPI at 4% could compress long-duration tech multiples further
  • Strong dollar hurts foreign revenue translation
  • Tariff/regulatory headline risk (general channels only)
⟋Technical analysis bullish · 62

AAPL is in a clean Stage 2 uptrend (Trend Template 8/8, price above all key MAs, RS line at a 52-week high), but short-term momentum and volume are unconvincing. It sits 2.15% below the 360.83 pivot with ADX only 18.1, falling OBV and a weak broad market (SPY below its 50-day with 8 distribution days). The best current setup is a possible breakout above 360.83, but it needs volume confirmation. A pullback entry near the 21 EMA/50 SMA is the lower-risk alternative.

Key findings

  • Long-term trend is strong: Stage 2 and Trend Template passes all 8 checks Price 353.24 vs SMA50 340.93, SMA150 316.11, SMA200 302.08; SMA200 1m slope +3.23%; 8/8 checks; 30w MA slope +3.68%
  • Leadership on relative strength RS line at 52w high; vs SPY +17.59 pts (3m), +21.67 pts (1y); vs sector +24.58 pts (3m); Mansfield RS 17.96
  • Momentum is healthy but not strong; trend strength is low RSI14 57.4 (normal 40-80 range in uptrends); MACD 4.055 > signal 3.688, hist +0.367; ADX 18.1 (<20 means weak trend/range), +DI 27.8 > -DI 20.2; possible bearish RSI divergence near highs
  • Volume does not confirm: mild distribution signals CMF20 -0.025; OBV 20d slope falling; up/down volume ratio 1.04; RVOL 0.32 on last bar (partial day, so low); distribution days 4 vs accumulation days 7 in 25 sessions
  • Volatility is moderate, with no squeeze and no true VCP ATR14 7.66 (2.17%); Bollinger %B 0.74; bandwidth percentile 26; choppiness 49.5; pullback depths 11.83% → 6.86% → 11.0% (not contracting); volume 10d/50d 0.95; NR7 true
  • Base is a 4-8 week range just under the pivot Range 325.08-360.83 (11.0%); pivot 20d high 360.83, distance 2.15%; resistance 355.11 and 360.83; Donchian20 high 360.83; round number 360

Risks

  • A breakout above 360.83 without volume of at least 1.5x average would likely fail, given falling OBV, negative CMF and RVOL below 1
  • Weak market regime (8 SPY distribution days) lowers breakout success rates
  • Possible bearish RSI divergence and ADX 18.1 suggest a range or consolidation rather than a trending advance
  • Pullbacks are not contracting, so the base is not a clean VCP
  • Account is $10,000 with $50 risk per trade, so a 2.17% ATR needs a small size and a stop of about 1 ATR or a structural level
⇄Positioning & sentiment neutral · 55

Positioning in AAPL is largely neutral-to-mildly-supportive of the Stage 2 uptrend. Short interest is tiny (1.0% of float) so there is no squeeze fuel. Insiders only sell (a weak signal), institutions are slightly net adding, and options are fairly priced. The main caution is the stressed market backdrop (VIX 25.5 in backwardation) and soft volume confirmation (CMF slightly negative, OBV falling).

Key findings

  • Short interest is negligible, so no squeeze potential and no bearish crowding 1.0% of float, days to cover 3.59, +19.9% vs prior month, squeeze_risk low. The rise is from a very small base.
  • Insider activity is all selling, which is a weak signal 0 open-market buys, 19 sales worth $111.86M in 180d, 0 distinct buyers. Without 10b5-1 plan detail, treat as routine (taxes, diversification).
  • Institutions are modestly net adding, with no sign of a crowded exit Institutions hold 66.38%. 5 of the top 10 holders are adding (FMR +13.72%, Invesco +2.12%, State Street +1.2%). BlackRock -0.51%, Vanguard Capital Mgmt -0.4%, JPM -1.78%. Berkshire flat at 1.57%. 13F data lags about 45 days.
  • Options show a fair price for volatility with a mild put skew, and the near-term expiry shows balanced activity 30d ATM IV 24.8%, IV/HV20 0.91 (fair), term structure normal/flat. 25d put-minus-call skew is 7.0 pts (5d) and 5.3 pts (30d), so there is some demand for protection. Dec-18 put/call volume is 2.61 but OI is 1.07. Nov-23 unusual volume is 1,149 puts and 904 calls at the 352.5 strike vs OI of 284 and 193, which is both-sided and likely a short-dated weekly/hedging trade, not a clear directional bet.
  • The expected move is modest Nov-23 straddle $8.38 (±2.37%, range 344.86–361.61). Dec-18 ±5.7% (333.09–373.39). The 5d expiry has median OI of only 281 and a 7% spread, so liquidity is poor.
  • Analyst actions are mixed but net constructive 1 upgrade (China Renaissance to Buy, PT 425), 1 downgrade. Targets range from Barclays Underweight $261 to China Renaissance $425. JPM PT 355 is near the current price of 353.24.

Risks

  • Market-wide stress (VIX backwardation) could trigger index-driven selling regardless of AAPL-specific positioning
  • Falling OBV and negative CMF could signal distribution near the 52w high of 360.83
  • Put skew of 5-7 pts shows some hedging demand, which could be a precursor to a pullback
  • Heavy passive ownership (BlackRock, Vanguard, State Street) means index outflows could hit the stock
  • Short interest is up 19.9% m/m, so a modest bearish build is possible, but it is from a very low base
⚡Trading plans

AAPL is a Stage 2 leader (Trend Template 8/8, RS line at a 52-week high) trading in a 325-361 range under a 360.83 pivot. The market backdrop is weak (SPY below its 50-day, 8 distribution days, VIX 25.5 in backwardation), and volume confirmation is soft. The day-trade bias is neutral-to-long, but only for planned setups near VWAP. The swing plan is a pullback buy near the 21 EMA, since a breakout above 360.83 needs volume to be trusted. The Donchian system is long on the 20-day but not yet on a new breakout.

◇Options

AAPL is a Stage 2 leader sitting about 2% under a 360.83 pivot, but fundamentals are neutral (39x P/E, base fair value ~235), macro is stressed (VIX 25.5 in backwardation) and volume confirmation is soft. IV is fair (30d ATM IV 24.8%, IV/HV20 0.91) and earnings are 71 days away, so there is no IV-crush issue. The account is $10,000 with a $100 options risk cap (1%), and every candidate has a max loss above that cap. The only candidate worth considering is the 355/360 bull call debit spread ($260 max loss), and it is a cap breach, so I recommend no structure for now.

⛨Risk management

Three of the four plans (day_1, day_3, swing) have hard violations in RISK_CHECKS and must be rejected. Only day_2, the VWAP pullback long, is valid, and I would allow it only at reduced size. VIX is 25.48 in backwardation, SPY is below its 50-day with 8 distribution days, and the account is $10k with a possible PDT limit, so capital preservation comes first. Overall risk is high for day trading and moderate for swing positions.

Risks

  • Market stress: VIX 25.48 (+47% over 1 month) in backwardation, SPY 4.22% below its 50-day, 8 distribution days in 25 sessions. This means wider gaps and more slippage.
  • Chop: 9 VWAP crosses and a midday session make stop-outs more likely. ATR14 is 2.17%, with a 24.8% annual volatility and a 2.58% 1-day VaR95.
  • Soft volume confirmation: CMF -0.025, OBV falling, 4 distribution vs 7 accumulation days. Insiders are only selling (19 sales, $111.86M, 0 buys, direction of recent Form 144s unverified).
  • Crowding in AAPL as a defensive winner (RS at a 52-week high) could reverse sharply if selling becomes indiscriminate.
  • Beta discrepancy (0.61 vs 1.09), so real market sensitivity is uncertain. Assume the higher figure for sizing.

Key data

Price$353.24
Market cap$5,126.89B
1M / 1Y return+4.13% / +32.53%
vs 52-week high-2.10%
Trend stageStage 2 - advancing (price above rising 30-week MA)
Trend Template8/8
RSI (14) / ADX57.4 / 18.1
ATR % of price2.17%
Support338.44, 325.32
Resistance355.11, 360.83
P/E (trailing / forward)39.3 / 33.4
EV / EBITDA30.0
FCF yield2.65%
ROIC96.8%
Net debt / EBITDA0.14
Street target (mean)$345.63
Next earnings2027-01-28
Avg earnings move2.53%
ATM implied vol23.9%
Options expected move2.37%
IV vs realizedfair
Short interest (float)1.00%
Market regimeuptrend under pressure (SPY below 50-day, above 200-day)
VIX / 10-yr yield25.48 / 5.06%

Figures are calculated from public market data at the time of the report and may be delayed or inaccurate.

Report details

Published
Prices and data as of
Data sourcesYahoo Finance · SEC EDGAR · FRED

Research methodology → · Disclaimer